Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy

Published:2024-07-23 Issue:1 Volume:20 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Ma Yue¹²^ORCID,Chen Shiyun¹²^ORCID,Dai Guanghai²^ORCID

Affiliation:

1. Department of Medical Oncology, Medical School of Chinese PLA, Beijing, China

2. Department of Medical Oncology, The First Medical Centre, Chinese PLA General Hospital, Beijing, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2024.2376429

Reference23 articles.

1. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. Advances in the epidemiology of pancreatic cancer: Trends, risk factors, screening, and prognosis

3. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors

4. Pancreatic cancer

5. Pancreatic cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP